24 hours of fasting did not prevent oxaliplatin-induced thrombocytopenia (Fig. S5k); improved the chemotherapy-induced loss of body weight (Fig. S5l); and protected from some biomarkers of neurotoxicity, as expression of the Myl1, Myh4, Tnnc2, Tnn3, and Cd74 genes, but did not protect from increased paw sensitivity in the von Frey assay (Fig. S5m). Here, MYL1 is linked to Thrombocytopenia.